-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G/M2wY/dvAisdoS2hARgyWRGKVRLR7/iTrH9EdIHNzjjGB+octjqSmItIPBsp4nf 7E/5lZxJfunK0RK+TRtZWQ== 0000874716-08-000005.txt : 20080131 0000874716-08-000005.hdr.sgml : 20080131 20080131143121 ACCESSION NUMBER: 0000874716-08-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080130 FILED AS OF DATE: 20080131 DATE AS OF CHANGE: 20080131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON REBECCA M CENTRAL INDEX KEY: 0001254748 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 08564086 BUSINESS ADDRESS: BUSINESS PHONE: 617 253 6618 MAIL ADDRESS: STREET 1: C/O MIT SLOAN SCHOOL ROOM E52-43 STREET 2: 50 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4henderson_qtrlydsuex.xml X0202 4 2008-01-30 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001254748 HENDERSON REBECCA M C/O MIT SLOAN SCHOOL ROOM E52-43 50 MEMORIAL DRIVE CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2008-01-30 4 A 0 202 55.62 A 7240 D Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units acquired is determined by dividing the amount of Director's cash compensation deferred pursuant to the Plan ($11,250) by the closing price of the IDEXX Laboratories, Inc. Common Stock on the date of the deferral. Deferred stock units are issuable only as common tock on a one-for-one basis one year following the Director's resignation from the Board of Directors. On November 5, 2007, the Common Stock of IDEXX Laboratories, Inc. split 2-for-1, resulting in the reporting person's ownership of 3,519 additional shares of common stock. John B. Rogers, Attorney-in-Fact for Rebecca M. Henderson, PhD 2008-01-31 -----END PRIVACY-ENHANCED MESSAGE-----